Li Dong-Tao, Cao Yi, Qiu Yi-Gang, Chen Yu, Zheng Jian-Yong
Department of Cardiology, Division of Cardiology and Cardiovascular Surgery, Sixth Medical Center of PLA General Hospital, Beijing, China.
Acta Cardiol Sin. 2024 Sep;40(5):577-584. doi: 10.6515/ACS.202409_40(5).20240617F.
Mechanical circulatory support may facilitate high-risk percutaneous coronary intervention (PCI). This study aimed to assess the feasibility, safety and effectiveness of high-risk PCI under the support of venoarterial extracorporeal membrane oxygenation (VA-ECMO) combined with intra-aortic balloon pump (IABP).
We enrolled patients who received VA-ECMO plus IABP-assisted PCI procedures at our center from April 2012 to June 2018. Major adverse cardiac events (MACEs) included all-cause death, myocardial infarction, and target vessel revascularization.
A total of 10 patients were included, with a mean age of 71 years, EuroSCORE II of 19.9%, and SYNTAX score of 39.8. Procedural success was achieved in nine (90%) patients. The mean duration of ECMO support was 1.5 hours, and 2.6 stents were implanted per patient. Major complications included contrast-induced nephropathy needing hemodialysis in one (10%) patient, significant hemoglobin drop requiring blood transfusion in two (20%) patients, pulmonary infection in one (10%) patient, and local surgical incision infection in one (10%) patient. The accumulative mortality rates for the nine patients with procedural success were 0, 22.2%, and 44.4% at 1, 3, and 5 years follow-up, respectively. However, cardiac death occurred in only one (11.1%) patient. In addition, two patients received repeat PCI or coronary artery bypass grafting within two years following the index procedure. The overall incidence rates of MACEs were 11.1%, 44.4%, and 66.7% at 1, 3, and 5 years follow-up, respectively.
VA-ECMO plus IABP-assisted high-risk PCI was feasible in patients with complex coronary disease, with a high procedural success rate and acceptable mid-term clinical outcomes.
机械循环支持可能有助于高风险经皮冠状动脉介入治疗(PCI)。本研究旨在评估静脉-动脉体外膜肺氧合(VA-ECMO)联合主动脉内球囊反搏(IABP)支持下高风险PCI的可行性、安全性和有效性。
我们纳入了2012年4月至2018年6月在本中心接受VA-ECMO加IABP辅助PCI手术的患者。主要不良心脏事件(MACE)包括全因死亡、心肌梗死和靶血管血运重建。
共纳入10例患者,平均年龄71岁,欧洲心脏手术风险评估系统(EuroSCORE)II评分为19.9%,SYNTAX评分为39.8。9例(90%)患者手术成功。ECMO支持的平均持续时间为1.5小时,每位患者植入2.6枚支架。主要并发症包括1例(10%)患者发生需要血液透析的造影剂肾病,2例(20%)患者血红蛋白显著下降需要输血,1例(10%)患者发生肺部感染,1例(10%)患者发生局部手术切口感染。9例手术成功患者在1年、3年和5年随访时的累积死亡率分别为0、22.2%和44.4%。然而,仅1例(11.1%)患者发生心源性死亡。此外,2例患者在首次手术后两年内接受了再次PCI或冠状动脉旁路移植术。在随访1年、3年和5年时,MACE的总体发生率分别为11.1%、44.4%和66.7%。
VA-ECMO加IABP辅助的高风险PCI在复杂冠心病患者中是可行的,手术成功率高,中期临床结局可接受。